| 注册
首页|期刊导航|Journal of Geriatric Cardiology|Natriuretic peptide family as diagnostic/prognostic biomarker and treatment modality in management of adult and geriatric patients with heart failure: remaining issues and challenges

Natriuretic peptide family as diagnostic/prognostic biomarker and treatment modality in management of adult and geriatric patients with heart failure: remaining issues and challenges

Zhen-Lu ZHANG Ran LI Fei-Yan YANG Lei XI

Journal of Geriatric Cardiology2018,Vol.15Issue(8):P.540-546,7.
Journal of Geriatric Cardiology2018,Vol.15Issue(8):P.540-546,7.DOI:10.11909/j.issn.1671-5411.2018.08.008

Natriuretic peptide family as diagnostic/prognostic biomarker and treatment modality in management of adult and geriatric patients with heart failure: remaining issues and challenges

Zhen-Lu ZHANG 1Ran LI 1Fei-Yan YANG 2Lei XI3

作者信息

  • 1. Department of Clinical Laboratory, Wuhan Asia Heart Hospital, Wuhan University, Wuhan, China
  • 2. Department of Cardiology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
  • 3. Division of Cardiology, Pauley Heart Center, Virginia Commonwealth University, Richmond, VA, United States
  • 折叠

摘要

关键词

Angiotensin-renin-neprilysin-inhibitors/Biomarker/BNP/Heart failure/NT-proBNP

分类

化学化工

引用本文复制引用

Zhen-Lu ZHANG,Ran LI,Fei-Yan YANG,Lei XI..Natriuretic peptide family as diagnostic/prognostic biomarker and treatment modality in management of adult and geriatric patients with heart failure: remaining issues and challenges[J].Journal of Geriatric Cardiology,2018,15(8):P.540-546,7.

Journal of Geriatric Cardiology

OACSCDSCI

1671-5411

访问量0
|
下载量0
段落导航相关论文